Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

PLAVIX Drug Profile

« Back to Dashboard

What is the patent landscape for Plavix, and when can generic versions of Plavix launch?

Plavix is a drug marketed by Sanofi Aventis Us and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-three patent family members in forty-three countries.

The generic ingredient in PLAVIX is clopidogrel bisulfate. There are fifty-three drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.

Summary for Tradename: PLAVIX

Suppliers / Packagers: see list11
Bulk Api Vendors: see list120
Clinical Trials: see list147
Patent Applications: see list2,071
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PLAVIX at DailyMed

Pharmacology for Tradename: PLAVIX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
clopidogrel bisulfate
TABLET;ORAL020839-001Nov 17, 1997ABRXYesNo6,429,210*PED► SubscribeY► Subscribe
Sanofi Aventis Us
clopidogrel bisulfate
TABLET;ORAL020839-002Sep 20, 2007ABRXYesYes6,504,030*PED► SubscribeY► Subscribe
Sanofi Aventis Us
clopidogrel bisulfate
TABLET;ORAL020839-001Nov 17, 1997ABRXYesNo6,504,030*PED► SubscribeY► Subscribe
Sanofi Aventis Us
clopidogrel bisulfate
TABLET;ORAL020839-002Sep 20, 2007ABRXYesYes6,429,210*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus